Métodos analíticos desenvolvidos para o monitoramento da doença citrus greening em laranja doce: imagens de fluorescência e espectroscopia de emissão óptica com plasma induzido por laser (LIBS).

bitstream/item/61173/1/BPD35-2011.pd

Métodos analíticos desenvolvidos para o monitoramento da doença citrus greening em laranja doce: imagens de fluorescência e espectroscopia de emissão óptica com plasma induzido por laser (LIBS).

Parte I: Espectroscopia de Emissão Ótica com Plasma Induzido por Laser (LIBS).; Parte II: Imagens de Fluorescência Molecular.bitstream/item/58460/1/BPD35-2012-1.pd

Caracterização de duas cultivares de soja RR para cultivo no Sul de Minas Gerais.

Avaliou-se duas cultivares de soja transgênicas RR (BRSMG 780RR e BRSMG 820RR) oriundas do Programa de Melhoramento Genético de Soja para o estado de Minas Gerais, convênio Embrapa/Epamig/Fundação Triângulo, submetidas à quatro populações de plantas (100.000, 200.000, 300.000 e 400.000 plantas ha-1). Utilizou se o delineamento de blocos casualizados com três repetições, determinando-se altura de plantas e de inserção de 1° legume, índice de acamamento, n° de legumes por planta, n° de grãos por legume, peso de 100 grãos e rendimento de grãos. As cultivares BRSMG 780RR e BRSMG 820RR mostraram alta plasticidade à medida que a variação na população de plantas alterou somente os índices de acamamento de plantas. No entanto, recomenda-se estudos por mais de um ano agrícola

Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis

OBJECTIVE: Non-pituitary tumors have been reported in a subset of patients harboring germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene. However, no detailed investigations of non-pituitary tumors of AIP-mutated patients have been reported so far. PATIENTS: We examined a MEN1- and p53-negative mother-daughter pair with acromegaly due to somatotropinoma. Subsequently, the mother developed a large virilizing adrenocortical carcinoma and a grade II B-cell non-Hodgkin's lymphoma. DESIGN: Mutational analysis was performed by automated sequencing. Loss-of-heterozygosity (LOH) analysis was carried out by sequencing and microsatellite analysis. AIP expression was assessed through quantitative PCR (qPCR) and immunohistochemistry. RESULTS: The functional inactivating mutation c.241C>T (R81X), which blocks the AIP protein from interacting with phosphodiesterase 4A (PDE4A), was identified in the heterozygous state in the leukocyte DNA of both patients. Analyzing the tumoral DNA revealed that the AIP wild-type allele was lost in the daughter's somatotropinoma and the mother's adrenocortical carcinoma. Both tumors displayed low AIP protein expression levels. Low AIP gene expression was confirmed by qPCR in the adrenocortical carcinoma. No evidence of LOH was observed in the DNA sample from the mother's B-cell lymphoma, and this tumor displayed normal AIP immunostaining. CONCLUSIONS: Our study presents the first molecular analysis of non-pituitary tumors in AIP-mutated patients. The finding of AIP inactivation in the adrenocortical tumor suggests that further investigation of the potential role of this recently identified tumor suppressor gene in non-pituitary tumors, mainly in those tumors in which the cAMP and the 11q13 locus are implicated, is likely to be worthwhile